BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Agaimy A, Vassos N, Märkl B, Meidenbauer N, Köhler J, Spatz J, Hohenberger W, Haller F, Croner RS, Schneider-stock R, Matzel K. Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach. Int J Colorectal Dis 2013;28:1057-64. [DOI: 10.1007/s00384-013-1655-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Shigaki T, Tsukada Y, Teramura K, Hasegawa H, Ikeda K, Nishizawa Y, Sasaki T, Ito M. Trans-anal surgery with the taTME technique for rectal gastrointestinal stromal tumors: a retrospective study. Int J Colorectal Dis 2022. [PMID: 35943579 DOI: 10.1007/s00384-022-04233-4] [Reference Citation Analysis]
2 Kim JC, Kim J, Jung J, Kim CW, Yoon YS, Park IJ. Implementation of robot-assisted curative resection for rare anorectal tumours on the basis of individualised treatment. Int J Med Robot 2021;:e2348. [PMID: 34741383 DOI: 10.1002/rcs.2348] [Reference Citation Analysis]
3 Addley S, Alazzam M, Johnson C, Soleymani Majd H. Rectovaginal extragastrointestinal stromal tumour (EGIST): an additional entity to be considered in the differential diagnosis of tumours of the rectovaginal septum. BMJ Case Rep 2021;14:e237669. [PMID: 33685909 DOI: 10.1136/bcr-2020-237669] [Reference Citation Analysis]
4 Li C, Wu H, Li H, Wang Q, Li Y, Gao ZD, Yang XD, Ye YJ, Jiang KW. Different Medical Features and Strategies of Large Rectal Gastrointestinal Stromal Tumor: A Multi-Central Pooling Analysis. Cancer Manag Res 2021;13:1591-600. [PMID: 33628049 DOI: 10.2147/CMAR.S291269] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
5 Qin X, Li C, Yang Z, Guo W, Guo H, Chen C, Huang R, Zhang D, Wang H, Wang H. Transsacrococcygeal approach in rectal gastrointestinal stromal tumour resection: 10-year experience at a single centre. Ann Transl Med 2021;9:341. [PMID: 33708968 DOI: 10.21037/atm-20-8204] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Jiaxin L, Peiyun Z, Zheng T, Wei Y, Shanshan S, Lei R, Zhengwen X, Yong F, Xiaodong G, Anwei X, Kuntang S, Yingyong H. Comparison of prognostic prediction models for rectal gastrointestinal stromal tumor. Aging (Albany NY) 2020;12:11416-30. [PMID: 32561689 DOI: 10.18632/aging.103204] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Sun Q, Su N, Li X, Hu Z, Wang W. Open transanal resection of low rectal stromal tumor following neoadjuvant therapy of imatinib mesylate: Report of 11 cases and review of literature. Asia Pac J Clin Oncol 2020;16:123-8. [PMID: 31957191 DOI: 10.1111/ajco.13292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Stuart E, Banerjee S, de la Torre J, Wang Y, Scherzer N, Burgoyne AM, Parry L, Fanta PT, Ramamoorthy S, Sicklick JK. Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry. J Surg Oncol 2019;120:715-21. [PMID: 31297829 DOI: 10.1002/jso.25621] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
9 Wu X, Li J, Xu W, Gao J, Li Y, Shen L. Postoperative imatinib in patients with intermediate risk gastrointestinal stromal tumor. Future Oncology 2018;14:1721-9. [DOI: 10.2217/fon-2017-0691] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
10 Kameyama H, Kanda T, Tajima Y, Shimada Y, Ichikawa H, Hanyu T, Ishikawa T, Wakai T. Management of rectal gastrointestinal stromal tumor. Transl Gastroenterol Hepatol 2018;3:8. [PMID: 29552659 DOI: 10.21037/tgh.2018.01.08] [Cited by in Crossref: 11] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
11 Cavnar MJ, Wang L, Balachandran VP, Antonescu CR, Tap WD, Keohan M, Singer S, Temple L, Nash GM, Weiser MR, Guillem JG, Aguilar JG, DeMatteo RP, Paty PB. Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome. Ann Surg Oncol 2017;24:3972-80. [PMID: 29058144 DOI: 10.1245/s10434-017-6087-9] [Cited by in Crossref: 25] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
12 Wada N, Takahashi T, Kurokawa Y, Nakajima K, Masuzawa T, Nakatsuka R, Kawada J, Nishida T, Kimura Y, Tanaka K, Miyazaki Y, Makino T, Yamasaki M, Takiguchi S, Mori M, Doki Y. Appropriate Follow-Up Strategies for Gastrointestinal Stromal Tumor Patients Based on the Analysis of Recurrent Interval and Patterns. Digestion 2017;95:115-21. [PMID: 28161699 DOI: 10.1159/000452656] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
13 Ueki T, Nagayoshi K, Manabe T, Maeyama R, Yokomizo A, Yamamoto H, Oda Y, Tanaka M. Laparoscopic en bloc excision of gastrointestinal stromal tumors of the rectum after neoadjuvant imatinib therapy: anteriorly extended intersphincteric resection combined with partial resection of the prostate. Tech Coloproctol 2015;19:247-51. [DOI: 10.1007/s10151-014-1261-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
14 Corless CL. Gastrointestinal stromal tumors: what do we know now? Mod Pathol. 2014;27 Suppl 1:S1-16. [PMID: 24384849 DOI: 10.1038/modpathol.2013.173] [Cited by in Crossref: 84] [Cited by in F6Publishing: 87] [Article Influence: 10.5] [Reference Citation Analysis]
15 Sun LF, He JJ, Yu SJ, Xu JH, Wang JW, Li J, Song YM, Ding KF, Zheng S. Transsacral excision with pre-operative imatinib mesylate treatment and approach for gastrointestinal stromal tumors in the rectum: A report of two cases. Oncol Lett 2014;8:1455-60. [PMID: 25202349 DOI: 10.3892/ol.2014.2406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
16 Pucciarelli S, Maretto I. Which is the best surgical approach for anorectal gastrointestinal stromal tumors in the post-imatinib era? Tech Coloproctol 2013;17:477-8. [PMID: 23624793 DOI: 10.1007/s10151-013-1015-x] [Reference Citation Analysis]